SGLT2阻害剤で治療された,新たに診断された糖尿病の猫における糖尿病寛解
Filip Lodarski1,2, Ghita Benchekroun2, Mario Cervone1
1Clinique Vétérinaire Sevetys Crozatier, Paris, France.
JFMS open reports
|February 12, 2026
まとめ
糖尿病の猫は,SGLT2阻害剤であるベラグリフロジンで治療した後に寛解を達成しました. このケースは,SGLT2阻害剤がネコ患者における糖尿病寛解を促進することを示唆しています.
科学分野:
- 獣医医学 獣医医学は,獣医医学というものです.
- 内分泌学 エンドックリノロジー
- 薬理学 薬理学とは
背景:
- 猫の糖尿病は,一般的な内分泌系疾患である.
- ステロイド誘発の糖尿病は猫にも発生する可能性があります.
- ナトリウム・グルコースコトランスポーター2 (SGLT2) 阻害剤は,ヒトにおける2型糖尿病の治療に使用されます.
研究 の 目的:
- SGLT2阻害剤で治療された猫の糖尿病の症例を報告する.
- 猫における血糖コントロールと糖尿病寛解の達成におけるヴェラグリフロジンの有効性を評価する.
- 猫の患者におけるヴェラグリフロジンの安全性と副作用を評価する.
主な方法:
- 糖尿病と診断された13歳のカストラされた雄性短毛猫は,ベラグリフロジンで治療された.
- 臨床症状,血糖コントロール (高血糖症,グルコスウリア,プラズマフルークトサミン),および副作用をモニタリングした.
- 糖尿病の寛解は,獣医内分泌学の合意言語のコンセンサス定義に基づいて評価されました.
主要な成果:
- ベラグリフロジン治療は,優れた血糖コントロール,体重増加,および臨床症状の解消をもたらしました.
- 猫は下痢を経験し,ベラグリフロジン投与を中止した後,下痢は治りました.
- 治療後の175日間,猫は糖尿病の寛解を達成し,維持しました.
結論:
- 糖尿病の寛解は,ベラグリフロジンなどのSGLT2阻害剤で治療された猫では達成可能である.
- SGLT2阻害剤は,猫の糖尿病に対する潜在的な治療の選択肢です.
- 猫におけるSGLT2阻害剤の長期的な有効性と安全性を調べるためにさらなる研究が必要である.
関連する概念動画
Pathophysiology of Diabetes
3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer
511
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
511
Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K


